The Report on the Asthma and COPD Drugs Market in the U.S. and China Analyzes the Current and Future Prospects of the Market
The market is slated to expand at a modest CAGR of 4.1% over the course of the forecast period, rising from a valuation of US$13.0 bn in 2015 to US$18.7 bn by 2024.
View full press release